文献速递焦虑、强迫与应激相关障碍心境障碍

战争杀戮影响的心理治疗:一项随机临床试验

Psychotherapy for Impact of Killing During War: A Randomized Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2026-08-05

这项多中心优势随机临床试验纳入100名因战争杀戮感到痛苦的退伍军人,比较IOK与PCT。结果显示两组心理社会功能均改善,但IOK在SDS上改善显著优于PCT,且在PTSD和道德伤害症状上改善更明显。

要点

  • IOK在SDS心理社会功能上显著优于PCT(Cohen d=-0.51,P=.02)。
  • IOK组PTSD和道德伤害症状改善显著优于PCT组。
  • 两组在WHOQOL-BREF心理社会功能上无显著差异。

核心结论

  • IOK可能改善因战争杀戮而痛苦的退伍军人的多个结局,包括心理社会功能、PTSD和道德伤害症状。

研究设计与样本

  • 共100名退伍军人随机分配至IOK或PCT,98名为男性,平均(SD)年龄48.4(13.7)岁。
  • 诊断评估由盲法评估者在筛选和治疗后实施,自评量表在基线、治疗中期、治疗后和6个月随访时收集。

主要发现

  • 线性混合模型显示两组在治疗后WHOQOL-BREF和SDS上心理社会功能均改善。
  • IOK组在SDS上改善显著优于PCT组(-3.50;z分数,-2.42;Cohen d,-0.51;P=.02;95%CI,-5.65至-0.59)。
  • 治疗后两组在WHOQOL-BREF上无显著差异。
  • 与PCT组相比,IOK组在PTSD和道德伤害症状上报告显著更大改善。

关键数值与推荐

  • 主要结局为WHOQOL-BREF和SDS评估的心理社会功能。
  • 次要结局包括PTSD和道德伤害测量。
  • 主要排除标准为精神病性障碍诊断、中度或重度酒精或物质使用障碍、未治疗躁狂或近期自杀或杀人行为。

临床怎么用

  • 对于因战争杀戮而痛苦的退伍军人,IOK可作为改善心理社会功能、PTSD和道德伤害症状的个体心理治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Killing in war is associated with multiple adverse outcomes, including posttraumatic stress disorder (PTSD), moral injury (MI), and suicide. Impact of killing (IOK) is an individual psychotherapy developed to treat the mental health impact of killing in war. OBJECTIVE: To determine whether IOK improves veterans' mental health symptoms and functioning at posttreatment and 6-month follow-up. DESIGN, SETTING, AND PARTICIPANTS: This multisite, superiority, randomized clinical trial was conducted from August 2018 to November 2023. Participants were veterans randomized to IOK or present-centered therapy (PCT). Diagnostic assessments were administered at screening and posttreatment by blinded evaluators. Self-report measures were collected at baseline, midtreatment, posttreatment, and 6-month follow-up at 3 Veterans Affairs health care systems in California, New York, and North Carolina via in-person and remote appointments. Participants were a sample of veterans with PTSD who reported distress related to killing in war or feeling responsible for the death of others. Primary exclusion criteria were a psychotic disorder diagnosis, moderate or severe alcohol or substance use disorder, untreated mania, or recent suicidal or homicidal behavior. INTERVENTIONS: IOK, an individual psychotherapy that focuses on killing cognitions, acceptance, self-forgiveness, and moral repair, and PCT, which addresses current functional issues due to moral distress with related problem-solving. MAIN OUTCOMES AND MEASURES: The primary outcomes were psychosocial functioning assessed by the World Health Organization Quality of Life Scale-Brief (WHOQOL-BREF) and the Sheehan Disability Scale (SDS). Secondary outcomes included PTSD and MI measures. RESULTS: A total of 100 individuals (98 male; mean [SD] age, 48.4 [13.7] years) were randomized. Linear mixed models revealed that psychosocial functioning improved for both groups at posttreatment (WHOQOL-BREF and SDS) and the IOK group had a significantly greater improvement than those in PCT on the SDS (-3.50; z score, -2.42; Cohen d, -0.51; P = .02; 95% CI, -5.65 to -0.59). There was no significant difference between treatments on the WHOQOL-BREF at posttreatment. Compared to PCT participants, IOK participants also reported significantly greater improvement in PTSD and MI symptoms. CONCLUSIONS AND RELEVANCE: Individuals in both treatments improved on measures of psychosocial functioning (WHOQOL-BREF and SDS). Those who received IOK evidenced greater improvements in work or school, social life, and home or family life (as measured by the SDS) compared to those in PCT at posttreatment. IOK participants also reported improved PTSD and MI symptoms. The findings suggest that IOK may improve several outcomes for those who experience distress due to killing in war. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03764033.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Maguen S, Gloria R, Lehrner A, et al. Psychotherapy for Impact of Killing During War: A Randomized Clinical Trial. JAMA Psychiatry. 2026. PMID: 42555019. doi:10.1001/jamapsychiatry.2026.2307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。